Literature DB >> 11311145

Mammalian inositol polyphosphate 5-phosphatase II can compensate for the absence of all three yeast Sac1-like-domain-containing 5-phosphatases.

C J O'Malley1, B K McColl, A M Kong, S L Ellis, A P Wijayaratnam, J Sambrook, C A Mitchell.   

Abstract

Phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P(2)] plays a complex role in generating intracellular signalling molecules, and also in regulating actin-binding proteins, vesicular trafficking and vacuolar fusion. Four inositol polyphosphate 5-phosphatases (hereafter called 5-phosphatases) have been identified in Saccharomyces cerevisiae: Inp51p, Inp52p, Inp53p and Inp54p. Each enzyme contains a 5-phosphatase domain which hydrolyses PtdIns(4,5)P(2), forming PtdIns4P, while Inp52p and Inp53p also express a polyphosphoinositide phosphatase domain within the Sac1-like domain. Disruption of any two yeast 5-phosphatases containing a Sac1-like domain results in abnormalities in actin polymerization, plasma membrane, vacuolar morphology and bud-site selection. Triple null mutant 5-phosphatase strains are non-viable. To investigate the role of PtdIns(4,5)P(2) in mediating the phenotype of double and triple 5-phosphatase null mutant yeast, we determined whether a mammalian PtdIns(4,5)P(2) 5-phosphatase, 5-phosphatase II, which lacks polyphosphoinositide phosphatase activity, could correct the phenotype of triple 5-phosphatase null mutant yeast and restore cellular PtdIns(4,5)P(2) levels to near basal values. Mammalian 5-phosphatase II expressed under an inducible promoter corrected the growth, cell wall, vacuolar and actin polymerization defects of the triple 5-phosphatase null mutant yeast strains. Cellular PtdIns(4,5)P(2) levels in various 5-phosphatase double null mutant strains demonstrated significant accumulation (4.5-, 3- and 2-fold for Deltainp51Deltainp53, Deltainp51Deltainp52 and Deltainp52Deltainp53 double null mutants respectively), which was corrected significantly following 5-phosphatase II expression. Collectively, these studies demonstrate the functional and cellular consequences of PtdIns(4,5)P(2) accumulation and the evolutionary conservation of function between mammalian and yeast PtdIns(4,5)P(2) 5-phosphatases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311145      PMCID: PMC1221798          DOI: 10.1042/bj3550805

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Functionally unrelated signalling proteins contain a fold similar to Mg2+-dependent endonucleases.

Authors:  M Dlakić
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

2.  The inositol polyphosphate 5-phosphatases and the apurinic/apyrimidinic base excision repair endonucleases share a common mechanism for catalysis.

Authors:  J C Whisstock; S Romero; R Gurung; H Nandurkar; L M Ooms; S P Bottomley; C A Mitchell
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

3.  Phosphatidylinositol 4,5-bisphosphate regulates two steps of homotypic vacuole fusion.

Authors:  A Mayer; D Scheglmann; S Dove; A Glatz; W Wickner; A Haas
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion.

Authors:  D Raucher; T Stauffer; W Chen; K Shen; S Guo; J D York; M P Sheetz; T Meyer
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

Review 5.  Sac phosphatase domain proteins.

Authors:  W E Hughes; F T Cooke; P J Parker
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

6.  Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.

Authors:  W Röschinger; A C Muntau; G Rudolph; A A Roscher; S Kammerer
Journal:  Mol Genet Metab       Date:  2000-03       Impact factor: 4.797

7.  Sustained elevation in inositol 1,4,5-trisphosphate results in inhibition of phosphatidylinositol transfer protein activity and chronic depletion of the agonist-sensitive phosphoinositide pool.

Authors:  C J Speed; C A Mitchell
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

8.  Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast.

Authors:  M Bagnat; S Keränen; A Shevchenko; A Shevchenko; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 9.  Actin cytoskeleton organization in response to integrin-mediated adhesion.

Authors:  P Defilippi; C Olivo; M Venturino; L Dolce; L Silengo; G Tarone
Journal:  Microsc Res Tech       Date:  1999-10-01       Impact factor: 2.769

10.  Essential role of phosphoinositide metabolism in synaptic vesicle recycling.

Authors:  O Cremona; G Di Paolo; M R Wenk; A Lüthi; W T Kim; K Takei; L Daniell; Y Nemoto; S B Shears; R A Flavell; D A McCormick; P De Camilli
Journal:  Cell       Date:  1999-10-15       Impact factor: 41.582

View more
  4 in total

1.  The synaptojanin-like protein Inp53/Sjl3 functions with clathrin in a yeast TGN-to-endosome pathway distinct from the GGA protein-dependent pathway.

Authors:  Seon-Ah Ha; Javad Torabinejad; Daryll B DeWald; Markus R Wenk; Louise Lucast; Pietro De Camilli; Richard A Newitt; Ruedi Aebersold; Steven F Nothwehr
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

Review 2.  Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae.

Authors:  Thomas Strahl; Jeremy Thorner
Journal:  Biochim Biophys Acta       Date:  2007-02-06

3.  The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate.

Authors:  Christopher J Stefan; Anjon Audhya; Scott D Emr
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

Review 4.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.